European Society of Cardiology
Welcome to the European Society of Cardiology
 
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Our mission: to reduce the burden of cardiovascular disease in Europe
 

WCC 2006 - Slides

 Slides of the World Congress of Cardiology 2006


TitleAuthorSession Number
Acute Coronary SyndromesKristensenFP4839
Acute reperfusion treatment of ST-elevation myocardial infarction VanDeWerfFP995
AFFIRM study - evaluation of LAA stunning ColonnaFP119
AHF Syndrom - epidemiologyGheorghiadeFP4853
Aims and design of EuroActionKotsevaFP2545
ArrhythmiasLindeFP4838
Basic ScienceSipidoFP4835
Benefit of Fondaparinux on mortality, ischaemic events and bleeding across the entire spectrumMehtaFP1745
Best management in rural areasNordrehaugFP2525
Best management in urban areasMontalescotFP2524
Biomarker strategy in acute coronary syndromesLindahlFP1385
Changes in in-hospitial treatment of heart failure TavazziFP2538
Clinical profile and in-hospital mortality of patients with acute heart failureNieminenFP2537
Comparing chronic heart failure guidelines - Similarities and differencesSwedbergP2
congress-documents  
C-reactive proteinBiasucci1753
Current use of percutaneous coronary intervention in EuropeMarcoFP2532
Definition of multivessel diseaseEeckhoutFP149
Definitions of the Metabolic SyndromeAlberti1764
DES versus BMS: an evidence-based approach to stent selection in real-world MarcoFP4826
Determinants of new onset diabetes among hypertensive patients GuptaFP4827
Determinants of new onset diabetes among hypertensive patients Zamorano-GomezFP4828
Discussant on WAVEVerheugtFP3412
Drug optionsTavazziFP1748
Effect of pioglitazone in stroke prevention in type 2 diabetesWilcoxFP120
Effect on mode and cause of death of initiation of treatment for chronic heart failure TavazziFP4832
Effect on mode and cause of death of initiation of treatment for chronic heart failure WillenheimerFP4831
Effects of Pioglitazone in patients with or without a history of stroke Ryden 
Elevation of troponins in acute heart failure: injury or infarct?MairP136
Embolic events in patients with atrial fibrillation and effective anticoagulationZahnFP117
EpidemiologySenniFP3433
ESC Guidelines: challenges for the futurePrioriFP979
Establishing networks for Acute Myocardial InfarctionElsaesserFP2526
Factor Xa inhibitors in atrial fibrillation TurpieFP1825
GIK in AMI after CREATE-ECLA and OASIS 6 - DiscussantLablancheFP125
Guidelines revisitedVanDeWerfFP2523
Heart failure - renal dysfunctionVanVeldhuisenFP3441
Heart failure and cardiomyopathiesPonikowskiFP4842
HF with preserved ejection fraction - Diagnosis in daily practiceFraserFP3436
Home or Hospital in Heart failure - the HHH studySwedbergFP991
Hope 2 - Update. DiscussantHallFP129
How to identify patients at high risk for strokeWeimarFP4844
How to treat percutaneouslySievertFP4847
Hypertension and risk factorsAgabiti Rosei4836
IIb/IIIa receptor blockade -In the cath lab or upstream?SteinhublFP1758
ImagingPintoFP4837
Impact of cath lab availability on outcome of acute coronary syndrome - ProWallentinFP139
Implantable cardioverter-defibrillator indicationsFernandezLozanoFP1749
Implantable cardioverter-defibrillator indicationsSwedbergFP1750
Implications of the EuroAction project for preventive cardiologyWoodFP2549
Important worldwide differences in outcomes among atherothrombotic patientsOhmanFP122
Indications of cardiac pacing and resynchronisation therapyVardasFP3409
Individual and community interventionsSchumannFP1763
Influence of the level of care on presentation and management of AFBreithardtFP3427
Interventional cardiology DeBruyneFP4840
JIKEI Heart Study - Valsartan in a Japanese population with hypertensionDahlof-MochizukiFP3419
JIKEI Heart Study: what did the study show? DiscussantGirerdFP3420
Long-term outcomes of STEMI after thrombolysis vs inter-hospital transport for primary PCIGittFP1742
Long-term pharmacological treatment after acute heart failure in EuropePonikowskiFP4857
Management of hypertension and other risk factors in diabetesRydenFP2544
Medical emergency teamsCokkinosFP4860
Moving towards a consensus on redefinition of myocardial infarctionThygesenFP3408
Multi-slice computed tomography VanhoenackerFP151
Multivessel disease - Invasive evaluationFearonFP152
Neurocardiogenic syncope and heart diseaseBrignoleFP4851
New developments in Pentasaccharides in Atrial FibrillationDeCaterinaFP1824
New-onset diabetes and antihypertensive drugsManciaFP2543
NiseritideDicksteinFP1009
Non-invasive diagnosisKownatorFP1004
OASIS 5 + 6 FONDAPARINUX - DiscussantSimoonsFP1746
One year outcome of Acute Coronary Syndrome in Europe 2005Behar994
Optimising management of ACS: insights from the new guidelinesFoxFP4325
Overview of large RCT of ACE inhibitors in stable patientsDagenaisFP4833
PEP-CHF Primary end-point at one yearDicksteinFP985
Percutaneous ablation: patient selection, techniques and resultsExtramianaFP5092
Percutaneous coronary intervention in the elderlyMarcoFP3430
Perindopril in elderly people with Chronic Heart FailureClelandFP984
Peri-procedural elevation of troponinsRavkildeFP135
PRAGUE 2 Trial - five years follow-upWidimskyFP1741
Predictive outcome factors in the real-world management of patients MontalescotFP3413
Prevention of bleeding in the setting of coronary artery disease MehtaFP1002
Principles of the nurse-led cardiovascular prevention programme JenningsFP2546
Refinement of the clinical definition of Myocardial InfarctionAlpert153
Role of atrial fibrillation ablation in heart failure patientsJaisFP1829
STEMI patients - results of OASIS 6 study and CREATE-ECLA trialDiazFP124
Syncope and falls in the elderlyKennyFP4852
The Availability of a Cath Lab Improves Outcome in ACS PatientsVanDeWerfFP140
The Availability of a Cath Lab Improves Outcome in ACS PatientsVanDeWerfFP142
The burden of haemorrhagic complications in patients undergoing cardioversionStellbrinkFP118
The Chronic Care Model Applied to Secondary Prevention of Cardiovascular Disease PearsonFP987
The myoblast approachSiminiakFP2529
The variable anatomy of the veno-atrial junction and left atrial appendageHoFP1102
Thienopyridines after CLARITY-PCI - an update for ST-elevation myocardial infarctionWitkowskiFP1757
Treatment of the metabolic syndromeDeedwaniaFP1767
Troponins in Acute Myocardial InfarctionGiannitsisFP134
UltrafiltrationPonikowskiFP1010
Valvular heart disease in the elderlyVahanianFP3431
What drives the prothrombotic state in atrial fibrillation?VanWagonerFP1822
Where are we in facilitated percutaneous coronary intervention VanDeWerfFP1759
 
Highlight On
Stay connected with the ESC - your way! Find out how